The global generic pharmaceutical industry is worth more than $40 billion and it is growing at an annual rate of 10-15%. Emerging World Pharma Inc. is one of few opportunities for investors to participate in this vast, recession-proof industry.
Emerging World Pharma Inc.’s strategic, in depth approach to investing in generic Pharma ensures that investments are made in the safest and most profitable emerging markets.
Joel Everret - Investor Relations Department
For more information Email Us